SCHEMBL19620650

SCHEMBL19620650

NC1=C(OSCc2ccccc2)C(=O)C(c2cccnc2)O1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.42
MAPT P10636 4/20 0.40
KDM4E B2RXH2 2/20 0.40
POLB P06746 2/20 0.40
TP53 P04637 1/20 0.39
MDM2 Q00987 1/20 0.39
ALDH1A1 P00352 2/20 0.38
PLA2G7 Q13093 1/20 0.36
TSHR P16473 2/20 0.35
USP2 O75604 1/20 0.35
MAPK1 P28482 1/20 0.35
CASP1 P29466 1/20 0.35
PKM P14618 1/20 0.35
LMNA P02545 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
GAA P10253 1/20 0.34
FPR1 P21462 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19620603 0.89 POLB (0.50) CYP19A1MAPTKDM4EPOLBTP53
SCHEMBL19620533 0.88 MAPT (0.42) CYP19A1MAPTKDM4EPOLBTP53
SCHEMBL19620569 0.83 PLA2G7 (0.39) CYP19A1MAPTTP53MDM2PLA2G7
SCHEMBL19620522 0.81 KDM4E (0.42) MAPTKDM4EPOLBMDM2ALDH1A1
SCHEMBL19620542 0.81 POLB (0.42) CYP19A1MAPTKDM4EPOLBRAB9A
SCHEMBL19620675 0.81 MAPT (0.42) MAPTKDM4EPOLBALDH1A1LMNA
SCHEMBL19620507 0.81 KDM4E (0.39) CYP19A1MAPTKDM4EPOLBALDH1A1
SCHEMBL19620570 0.81 MAPT (0.39) MAPTKDM4EPOLBTP53MDM2
SCHEMBL22902049 0.81 MAPT (0.39) CYP19A1MAPTKDM4EPOLBALDH1A1
SCHEMBL19620689 0.80 KDM4E (0.38) CYP19A1MAPTKDM4EPOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3345596-B1 INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER RHODE ISLAND HOSPITAL (US) 2021-01-20 EP disclosed
EP-3345596-A2 INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER RHODE ISLAND HOSPITAL (US) 2018-07-11 EP disclosed
EP-2897607-B1 INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER RHODE ISLAND HOSPITAL (US) 2017-11-22 EP disclosed